Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation

Stroke - United States
doi 10.1161/strokeaha.116.016275
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Yearbook of Cardiology
2012English

Dabigatran Challenges Warfarin's Superiority for Stroke Prevention in Atrial Fibrillation

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2010English

Comparison of Dabigatran Etexilate Versus Warfarin, Asprin & No Treatment for Stroke Prevention in Atrial Fibrillation in England, United Kingdom, Over 5 Years

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Pharmacoeconomic Analysis of Dabigatran in Patients With Atrial Fibrillation: Comparison With Rivaroxaban or Apixaban

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Warfarin Versus Warfarin and Aspirin in Atrial Fibrillation

Neurological Bulletin
2011English

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

Pcv79 - Real-World Cost-Effectiveness of Rivaroxaban Compared With Vitamin K Antagonists in the Context of Stroke Prevention in Atrial Fibrillation in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Rivaroxaban Precision Dosing Strategy for Real World Atrial Fibrillation Patients

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2020English

Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy